Latest Conference Articles

Following the novel gene-editing tech's approval for the treatment of cancer last year, researchers at Roski Eye Institute are exploring its potential to treat ophthalmic disease.

The technology includes enhanced features like a patient management system that increases the ease of use for physicians.

The 14-point guideline included recommendations for initial psychiatric evaluation and assessment, treatment goals and plans, use of multiple medications, and for patients that are pregnant or breastfeeding.

MDD and PTSD are significantly associated with military trauma and PTSD specifically, is at an increased with military sexual trauma among females.

The use of the popular smartphone application Pokémon GO—and possibly similar games—could have potential therapeutic benefits for those with mental illness.

The HeartLight Excalibur Balloon, designed for the treatment of paroxysmal atrial fibrillation, is ultra-compliant and can be resized in real-time.

According to survey data released by the American Psychiatric Association, almost 50% of Americans believe the crisis is impacting their peers, and 31% know someone addicted to opioids.

Wahida Karmally, MS, RD, CDE, explains the challenges and importance of diet in patients with familial chylomicronemia syndrome (FCS), how much fat can be eaten (and which kind), and the dangers of pancreatitis when too much fat is consumed.

EpiFinder, a mobile health application, predicted either an epilepsy syndrome or alternative diagnosis with 86.8% accuracy.

If approved, therapy would be the first of its kind to target Glx for the treatment of bipolar depression.

The mean level of anxiety has increased 5 points since 2017 on a 100-point scale, with Baby Boomers reporting a 7-point jump over the last year.

Abhimanyu Garg, MD, discusses the cofactors and concerns in FCS treatments.

Abhimanyu Garg, MD, indicates the importance of neonatal screening for familial chylomicronemia syndrome (FCS).

Women who continued using antipsychotic medications during pregnancy had an absolute risk of 4.2% to 12% of developing gestational diabetes.

History of psychiatric disorder, especially in fathers and brothers, is highly valuable information to identify women most at risk for postpartum psychiatric illness.

Patients that had their medication selection guided by the GeneSight pharmacogenomic testing were 50% more likely to achieve remission and 30% more likely to achieve treatment response.

Patients with cannabis and cocaine use disorder have different impulsivity profiles, especially with relation to differences in attentional impulsiveness.

Results demonstrate potential to address a significant unmet for more than 30% of those suffering from treatment-resistant depression.

John Greden, MD, discussed the challenges physicians face in diagnosing, identifying, and treating depression, and the populations that are still severely underserved.

Darrell Kirch, MD, spoke at the APA’s annual meeting about the impact physician burnout has had and what can be done to address it and to improve clinician well-being.

Mayumi Okuda, MD, talked about what clinicians need to be doing and aware of in the identification of patients experiencing intimate partner violence.

Firearm use in the not guilty by reason of insanity population is more closely related to substance use and personality disorder than psychotic or mood disorders.

The associated PTSD comorbidities represent a significant public health problem that’s concomitant with increased disease burden and mortality.

Mayumi Okuda, MD, discussed Columbia's Chapman Perelman Domestic Violence Initiative, a program designed to help victims of abuse get the help and resources they need on their home turf.

The use of electroconvulsive therapy in patients with bipolar depression resulted in higher remission rates while showing similar response rates to unipolar major depression.

The algorithm is intended to help prevent mistakes caused by a slew of issues, from burnout at the end of a long day to overconfidence in decision-making.

Alan S. Brown, MD, FNLA, FACC, FAHA is a Cardiologist at Advocate Lutheran General Hospital and the President-Elect of the National Lipid Association (NLA). While at the NLA’s 2018 Scientific Sessions in Las Vegas, Nevada, he explained the connection between hypertriglyceridemia and FCS.

Alan S. Brown, MD, FNLA, FACC, FAHA, reviews emerging treatments and research for familial chylomicronemia syndrome (FCS).

Nanophotoswitches have demonstrated promising results in rats. Will they one day improve transduction in damaged eyes, and restore lost vision in humans?

The burden of ophthalmic disease is rising. How can ophthalmologists rise to meet it?